LC capilliposide

antineoplastic agent extracted from Lysimachia capillipes

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 01/01/2014 - "These findings demonstrate that LC capilliposide could exert an anti-tumor effect on NSCLC through mitochondrial-mediated apoptotic pathway and the activation of ROS is involved. " 01/01/2017 - "In a PC-9-GR xenograft mouse model, combination treatment with LC capilliposide (15 mg·kg-1·d-1, ip) and gefitinib (50 mg·kg-1·d-1, ip) dramatically enhanced tumor growth suppression (with a TGI of 109.3%), compared with TGIs of 22.6% and 56.6%, respectively, in mice were treated with LC capilliposide or gefitinib alone. "
2.	Lung Neoplasms (Lung Cancer) 01/01/2014 - "Our results indicated that LC capilliposide inhibited proliferation of lung cancer cells in a dose-dependent manner. "

1.	Gefitinib (Iressa)